Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism
about
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative studyThe E-screen assay: a comparison of different MCF7 cell stocksNomegestrol acetate: pharmacology, safety profile and therapeutic efficacy.New progestagens for contraceptive use.The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cellsProgestogens and membrane-initiated effects on the proliferation of human breast cancer cells.Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75.Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCF-7 cells.An appraisal of strategies to reduce the incidence of breast cancer.New insight on a possible mechanism of progestogens in terms of breast cancer risk.Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression.Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women.Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.Investigation on the Interaction of Norgestrel with Human Serum Albumin Using Spectroscopy and Molecular-Docking Method.
P2860
Q28249558-922A7E25-AFE1-4C22-B2D7-673D95526B41Q28367480-8163397A-9E5B-45BA-8BB7-1284032455D2Q34106288-EF55BEA5-B1EB-4C3B-B053-94413238BBC0Q34468158-34BF8D6A-C999-40BC-8B4D-7603B85DF50EQ34932849-C6E612F5-DBD8-4C43-9AC8-9D7E41855AACQ35827822-B3AEFD8C-644F-46B1-B0F8-E9A4681356B8Q36598699-0FA1639A-AD1C-47B4-8184-BE3889D0AAB8Q36672641-EDAF253A-6A1E-4119-8A4B-CF7F383A5565Q38327714-7A62744B-C051-418E-943B-846FAA36DFD4Q39865023-07ACB94C-E274-4308-8376-23D83FF27343Q40370748-749A72B7-508E-4499-9F8C-417CB4479F9DQ40742855-FF014AA0-154A-454C-A046-E2B93F4D71E2Q40860406-CB75AACE-FD89-46D0-BB17-432C7CB3D245Q40953525-E2F25349-D8A7-4612-8178-F0E53869501DQ42445773-9AD9C81D-7553-4EF8-8507-7EF5EBE80F2CQ44011321-624A9FAE-0459-4838-BE5A-51FC0C3E26E5Q44871715-C41B34E0-5F93-47DD-BF30-03BDC5F09C45Q46602710-4217F9BA-DC8C-4F83-A92D-CACD9DB01703Q51557691-6A9F2DF5-F7BF-4ED8-8031-456C044302DE
P2860
Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Norgestrel and gestodene stimu ...... en receptor mediated mechanism
@ast
Norgestrel and gestodene stimu ...... en receptor mediated mechanism
@en
type
label
Norgestrel and gestodene stimu ...... en receptor mediated mechanism
@ast
Norgestrel and gestodene stimu ...... en receptor mediated mechanism
@en
prefLabel
Norgestrel and gestodene stimu ...... en receptor mediated mechanism
@ast
Norgestrel and gestodene stimu ...... en receptor mediated mechanism
@en
P2093
P2860
P356
P1476
Norgestrel and gestodene stimu ...... en receptor mediated mechanism
@en
P2093
V C Jordan
W H Catherino
P2860
P2888
P304
P356
10.1038/BJC.1993.175
P407
P577
1993-05-01T00:00:00Z